24/7 Patient Assistance: 760-405-8205

George Schiffman, MD

Pulmonologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Diffuse Pleural Thickening Lung Cancer Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis

Hospitals & Clinics

specialties & services

  • Bio & Insurance Information

    Dr. George Schiffman is a pulmonologist in Mission Viejo, California and he works at Mission Hospital. He got his diploma from Rush Medical College and did his residency in Internal Medicine at the University of California Irvine, where he also did a fellowship in Pulmonary Disease. The doctor is certified in Critical Care Medicine, Internal Medicine, Pulmonary Disease, Sleep Medicine and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Rush Medical College

    Medical School

    dept_icon

    University of California Irvine

    Residency

    dept_icon

    University of California Irvine

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Critical Care Medicine

    American Board of Internal Medicine - Pulmonary Disease

    American Board of Sleep Medicine

  • Hospital & Practice

    Mission Hospital

    Languages: English/Spanish

    (949) 364-1400

    27700 Medical Center Rd

    Mission Viejo, California 92691

    Read More
  • Publications & Memberships

    Dr. George Schiffman has contributed to 3 publications.

    Indomethacin and perception of dyspnea in chronic airflow obstruction.

    Schiffman, G. L., Stansbury, D. W., Fischer, C. E., Sato, R. I., Light, R. W., Brown, S. E.; Am Rev Respir Dis. 1988 May.

    See more >>

    Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure.

    Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ; Am. Rev. Respir. Dis.. 1984-12-01.Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ; Am. Rev. Respir. Dis.. 1984-12-01.

    See more >>

    Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial).

    Thomas, G.S., Tammelin, B.R., Schiffman, G.L., Marquez, R., Rice, D.L., Milikien, D., Mathur, V.; J Nucl Cardiol. 2008-05-01.

    See more >>